Analysts View Astellas’ Pick Of Former Pfizer Exec To Head Global Development As Nod To Daiichi Sankyo's Success

TOKYO - Astellas Pharma's decision to move its global development headquarters to Illinois may be a reflection of how other major Japanese pharmas see Daiichi Sankyo's position in the market, a Japanese analyst says